Free delivery to Riyadh, Jeddah, Abha on orders over 100 SAR.
Xefo contains the active substance "Lornoxicam", a non-steroidal anti-inflammatory drug (NSAID), which helps alleviate inflammation and relieve pain.
Relieving moderate or severe pain.
Relieve inflammation in osteoarthritis.
Pain relief in case of rheumatoid arthritis.
The doctor determines the appropriate dose of the Xefo injection.
The usual dose is 8 mg (one injection) with intramuscular or intravenous injections.
Maximum daily dosage is 16 mg (2 injections).
Some patients may need an additional 8 mg in the first 24 hours.
Gastric ulcers.
Gastrointestinal bleeding (may be fatal especially in the elderly).
Nausea.
Vomiting.
Sleepiness.
Diarrhea.
Bloating.
indigestion.
Xefo injections are not used in case of:
Hypersensitivity to the ingredients of the drug.
People younger than 18.
Thrombocytopenia.
Severe heart failure.
Gastrointestinal bleeding or any bleeding.
Previously suffering from gastrointestinal bleeding or perforation, as a result of taking non-steroidal anti inflammatory (NSAID).
Gastric ulcers.
Severe liver failure.
Severe kidney failure.
The last trimester of pregnancy.
Care should be taken before using Xefo injections, especially in the case of:
kidney failure.
liver failure.
Blood clot disorders.
Use the drug for more than 3 months.
Older people.
Xefo is not used during pregnancy, especially in the last trimester.
The drug may be transmitted through breast milk to the infant, so Xefo should not be used during the breastfeeding period.
Keep out of children's reach.
Keep at a temperature of less than 25 ° C.